Biblio

15 Ergebnisse exportiert:
[ Autor(Desc)] Titel Typ Jahr
Filterkriterien: Anfangsbuchstabe Des Titels is V  [Alle Filter deaktivieren]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, u. a.. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A [Internet]. 1998;95(2):548 - 53. http://view.ncbi.nlm.nih.gov/pubmed/9435229PDF Icon Marc Achen et al., PNAS 1998 (447.59 KB)
B
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, u. a.. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974PDF Icon Maija Bry et al., Circulation 2010 (2.23 MB)PDF Icon Maija Bry et al., Circulation 2010, supplement (17.77 MB)
G
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, u. a.. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol [Internet]. 2003;161(6):1163 - 77. http://view.ncbi.nlm.nih.gov/pubmed/12810700PDF Icon Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB)
H
He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, u. a.. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res [Internet]. 2005;65(11):4739 - 46. http://view.ncbi.nlm.nih.gov/pubmed/15930292PDF Icon Yulong He et al., Cancer Research 2005 (1.82 MB)
J
Jeltsch M. VEGFR-3 Ligands and Lymphangiogenesis [Internet]. University of Helsinki. 2002. http://ethesis.helsinki.fi/julkaisut/mat/bioti/vk/jeltschPDF Icon Michael Jeltsch, PhD Thesis, 2002 (1.75 MB)
Jeltsch M, Karpanen T, Strandin T, Aho K, Lankinen H, Alitalo K. Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns. J Biol Chem [Internet]. 2006;281(17):12187 - 95. http://view.ncbi.nlm.nih.gov/pubmed/16505489PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006 (1.04 MB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 1 (1.01 MB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 2 (596.06 KB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 3 (738.98 KB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 4 (710.03 KB)PDF Icon Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 5 (163.64 KB)
Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, u. a.. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol [Internet]. 1997;173(2):211 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9365524PDF Icon Vladimir Joukov et al., Journal of Cellular Physiology 1997 (127.57 KB)
K
Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, u. a.. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol [Internet]. 2004;5(1):74 - 80. http://view.ncbi.nlm.nih.gov/pubmed/14634646PDF Icon Marika Kärkkäinen et al., Nature Immunology 2004 (3.01 MB)PDF Icon Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 1 (1.27 MB)PDF Icon Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 2 (1.23 MB)
Krebs R, Tikkanen JM, Ropponen JO, Jeltsch M, Jokinen JJ, Ylä-Herttuala S, u. a.. VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease. Journal of Heart and Lung Transplantation. 2011;30:S118 - S118.
Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, u. a.. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development [Internet]. 1996;122(12):3829 - 37. http://view.ncbi.nlm.nih.gov/pubmed/9012504PDF Icon Eola Kukk et al., Development 1996 (805.94 KB)
M
Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, u. a.. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J [Internet]. 2001;20(4):672 - 82. http://view.ncbi.nlm.nih.gov/pubmed/11179212PDF Icon Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)
O
Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JE, Weich HA, Christ B, u. a.. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol [Internet]. 1997;188(1):96 - 109. http://view.ncbi.nlm.nih.gov/pubmed/9245515PDF Icon Su-Ja Oh et al., Developmental Biology 1997 (3.28 MB)
Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, u. a.. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A [Internet]. 1998;95(20):11709 - 14. http://view.ncbi.nlm.nih.gov/pubmed/9751730PDF Icon Birgitta Olofsson et al., PNAS 1998 (470.59 KB)
P
Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol [Internet]. 1998;177(3):439 - 52. http://view.ncbi.nlm.nih.gov/pubmed/9808152PDF Icon Michael Pepper et al., Journal of Cellular Physiology 1998 (689.97 KB)
R
Rauniyar K. VEGF-C: The evolutionary origin, activation, and potential as a drug target [Internet]. [Helsinki. Finland]: University of Helsinki; 2023. http://hdl.handle.net/10138/357923PDF Icon Rauniyar - 2023 - VEGF-C: The evolutionary origin, activation, and potential as a drug target (3.09 MB)